Heparin-induced thrombocytopenia and arterialthrombosis: Alternative therapies (Q33372164)

26 July 2017

1 reference

title

Heparin-induced thrombocytopenia and arterial thrombosis: alternative therapies (English)

1 reference

26 July 2017

Heparin-induced thrombocytopenia and arterialthrombosis: Alternative therapies (English)

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80029-8

29 October 2022

1 reference

1 reference

heparin-induced thrombocytopenia

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1689094

29 October 2022

dermatan sulfate

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1689094

Cardiology and cardiovascular medicine

29 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80029-8

29 October 2022

author name string

C. Cola

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1689094

29 October 2022

J. Ansell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1689094

29 October 2022

language of work or name

English

0 references

publication date

1 February 1990

1 reference

full work available at URL

26 July 2017

https://api.elsevier.com/content/article/PII:S0002870305800298?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80029-8

https://api.elsevier.com/content/article/PII:S0002870305800298?httpAccept=text/plain

29 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80029-8

29 October 2022

published in

American Heart Journal

1 reference

26 July 2017

volume

119

1 reference

26 July 2017

issue

2 Pt 1

1 reference

26 July 2017

page(s)

368-374

1 reference

Mechanism of action and monitoring of anticoagulants

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Low-dose heparin: Is the risk worth the benefit?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

HEPARIN REACTIONS IN PATIENTS WITH VASCULAR DISEASE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Bibliographies on diseases of medical progress. Adverse reactions to heparin and heparinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Heparin-induced thrombocytopenia and recurrent thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Heparin-induced thrombocytopenia. An unexpected response to treatment of consumption coagulopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Heparin-associated thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Thrombocytopenia associated with antiheparin antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Heparin-induced thrombocytopenia and thrombosis: detection and specificity of a platelet-aggregating IgG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Heparin-induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Thrombocytopenia during heparin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Heparin-induced thrombocytopenia: association with a platelet aggregating factor and arterial thromboses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Thrombocytopenia Found Uncommonly During Heparin Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Heparin-induced thrombocytopenia. What is its real frequency?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Low incidence of thrombocytopenia during treatment with hog mucosa and beef lung heparin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Heparin-associated thrombocytopenia: case report and prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Incidence of thrombocytopenia in medical patients on "mini-dose" heparin prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Heparin-associated thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Arterial Embolism Occurring During Systemic Heparin Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Heparin induced thrombocytopenia: eight cases with thrombotic-hemorrhagic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

The dangers of intermitten intravenous heparin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Letter: Fatal embolism despite heparin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Immune endothelial-cell injury in heparin-associated thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Letter: Heparin: adverse reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Heparin necrosis: an anticoagulant-induced cutaneous infarct

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Thrombotic complications of heparin therapy: including six cases of heparin--induced skin necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Heparin-associated thrombocytopenia. In vitro effects of different molecular weight heparin fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Critical ischemia during heparin-induced thrombocytopenia. Treatment by intra-arterial streptokinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Dextran 40 reduces heparin-mediated platelet aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Surgical management of heparin-associated thrombocytopenia. Strategies in the treatment of venous and arterial thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Aspirin prevents heparin-induced platelet aggregation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Management of patients with heparin-associated thrombocytopenia and thrombosis requiring cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

Extracorporeal circulation in a patient with heparin-induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980029-8

inferred from DOI database lookup

7 January 2021

based on heuristic

The effect of commercial heparin on the platelet count

9

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80029-8

Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia

29 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80029-8

Heparin-associated thrombocytopenia: low frequency in 104 patients treated with heparin of intestinal mucosal origin

29 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80029-8

Heparin induced thrombocytopenia: case reports and a prospective study

29 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80029-8

Embolization of platelet agglutination thrombi in the hamster's pouch produced by heparin

29 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80029-8

Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations

29 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80029-8

White clot syndrome: a rare complication of heparin therapy

29 October 2022

56

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80029-8

Heparin-induced thrombosis (white clot syndrome) secondary to prophylactic subcutaneous administration of heparin

29 October 2022

57

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80029-8

White clot syndrome associated with heparin-induced thrombocytopenia: a review of 23 cases

29 October 2022

58

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80029-8

Effects of unfractionated and fractionated heparin on platelet function

29 October 2022

63

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80029-8

29 October 2022

Identifiers

1 reference

26 July 2017

1 reference